Erratum: Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling (PLoS ONE (2013) 8:2 (e57708) DOI: 10.1371/journal.pone.0057708);Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lee, Sui Ting ^a   Wong, Pooi Fong ^a   He, Hui ^b   Da Hooper, Johnvid ^b   Mustafa, Mohd Rais ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELLULAR INHIBITOR OF APOPTOSIS 1 PROTEIN; CELLULAR INHIBITOR OF APOPTOSIS 2 PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; SURVIVIN; TOMATINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ASSAY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT;

EID: 84874337747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0268234     Document Type: Erratum

References (57)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Bracarda S, de Cobelli O, Greco C, Prayer-Galetti T, Valdagni R, et al. (2005) Cancer of the prostate. Crit Rev Oncol Hematol 56: 379-396.
3. Dagher R, Li N, Abraham S, Rahman A, Sridhara R, et al. (2004) Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer. Clin Cancer Res 10: 8147-8151.
4. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ, (2001) Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20: 4188-4197.
5. Surh J, Payvandi F, Edelstein L, Amenta P, Zong W, et al. (2002) Mechanisms of constitutive NF-kB activation in human prostate cancer cells. Prostate 52: 183-200.
6. Yemelyanov A, Gasparian A, Lindholm P, Dang L, Pierce JW, et al. (2006) Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene 25: 387-398.
7. Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, et al. (2008) The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Res 68: 6762-6769.
8. Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, et al. (2004) Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res 10: 5501-5507.
9. Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, et al. (2004) Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 10: 8460-8464.
10. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, et al. (2002) The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 115: 141-151.
11. Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, et al. (2005) Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer 93: 1285-1294.
12. Morrow WJ, Yang YW, Sheikh NA, (2004) Immunobiology of the Tomatine adjuvant. Vaccine 22: 2380-2384.
13. Friedman M, Lee KR, Kim HJ, Lee IS, Kozukue N, (2005) Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. J Agric Food Chem 53: 6162-6169.
14. Friedman M, Levin CE, Lee SU, Kim HJ, Lee IS, et al. (2009) Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J Agric Food Chem 57: 5727-5733.
15. Shieh JM, Cheng TH, Shi MD, Wu PF, Chen Y, et al. (2011) alpha-Tomatine Suppresses Invasion and Migration of Human Non-Small Cell Lung Cancer NCI-H460 Cells Through Inactivating FAK/PI3K/Akt Signaling Pathway and Reducing Binding Activity of NF-kappaB. Cell Biochem Biophys 60: 297-310.
16. Shih YW, Shieh JM, Wu PF, Lee YC, Chen YZ, et al. (2009) Alpha-tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: effect on metastasis. Food Chem Toxicol 47: 1985-1995.
17. Friedman M, McQuistan T, Hendricks JD, Pereira C, Bailey GS, (2007) Protective effect of dietary tomatine against dibenzo[a,l]pyrene (DBP)-induced liver and stomach tumors in rainbow trout. Mol Nutr Food Res 51: 1485-1491.
18. Lee ST, Wong PF, Cheah SC, Mustafa MR, (2011) Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells. PLoS ONE 6: e18915.
19. Luk SU, Lee TK, Liu J, Lee DT, Chiu YT, et al. (2011) Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One 6: e19804.
20. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, et al. (2011) Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer 128: 2182-2191.
21. Barnett SF, Defeo-Jones D, Fu S, Hancock PJ, Haskell KM, et al. (2005) Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem J 385: 399-408.
22. Estrada AC, Syrovets T, Pitterle K, Lunov O, Buchele B, et al. (2010) Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells. Mol Pharmacol 77: 378-387.
23. Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, et al. (2011) Vitamin E delta-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-kappaB activation in pancreatic cancer. Mol Cancer Ther 10: 2363-2372.
24. Sethi G, Ahn KS, Pandey MK, Aggarwal BB, (2007) Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 109: 2727-2735.
25. Plymate SR, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, et al. (2003) Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene 22: 1024-1034.
26. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M, (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.
27. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
28. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
29. Plati J, Bucur O, Khosravi-Far R, (2011) Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 3: 279-296.
30. Tang Y, Parmakhtiar B, Simoneau AR, Xie J, Fruehauf J, et al. (2011) Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia 13: 108-119.
31. Sethi G, Tergaonkar V, (2009) Potential pharmacological control of the NF-kappaB pathway. Trends Pharmacol Sci 30: 313-321.
32. Karin M, Lin A, (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
33. Gupta SC, Sundaram C, Reuter S, Aggarwal BB, (2010) Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799: 775-787.
34. Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, et al. (2004) Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian J Exp Biol 42: 341-353.
35. Hoeflich K, Luo J, Rubie E, Tsao M, Jin O, et al. (2000) Requirement for glycogen synthase kinase-3 beta in cell survival and NF kappaB activation. Nature 406: 86-90.
36. Lee F, Peters R, Dang L, Maniatis T, (1998) MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc Natl Acad Sci U S A 95: 9319-9324.
37. Sakurai H, Miyoshi H, Toriumi W, Sugita T, (1999) Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem 274: 10641-10648.
38. Yang J, Lin Y, Guo Z, Cheng J, Huang J, et al. (2001) The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2: 620-624.
39. Cragg GM, Grothaus PG, Newman DJ, (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109: 3012-3043.
40. Khan N, Adhami VM, Mukhtar H, (2010) Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer 17: R39-52.
41. Nobili S, Lippi D, EwaWitort, Donninic M, Bausi L, et al. (2009) Natural compounds for cancer treatment and prevention. Pharmacological Research 59: 365-378.
42. Das KC, White CW, (1997) Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. J Biol Chem 272: 14914-14920.
43. Uetsuka H, Haisa M, Kimura M, Gunduz M, Kaneda Y, et al. (2003) Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. Exp Cell Res 289: 27-35.
44. Wang W, McLeod HL, Cassidy J, (2003) Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer 104: 504-511.
45. Catz SD, Johnson JL, (2001) Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20: 7342-7351.
46. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, et al. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8538.
47. Zhu L, Fukuda S, Cordis G, Das DK, Maulik N, (2001) Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 508: 369-374.
48. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, et al. (1998) Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 188: 211-216.
49. Gill C, Dowling C, O'Neill AJ, Watson RW, (2009) Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. Mol Cancer 8: 39.
50. Akimoto T, Nonaka T, Ishikawa H, Sakurai H, Saitoh JI, et al. (2001) Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int J Radiat Oncol Biol Phys 50: 195-201.
51. Fulda S, Debatin KM, (2004) Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23: 6702-6711.
52. Komatsu K, Tauchi H, Yano N, Endo S, Matsuura S, et al. (1997) Inhibitory action of (-)-epigallocatechin gallate on radiation-induced mouse oncogenic transformation. Cancer Lett 112: 135-139.
53. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, et al. (2009) Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 125: 2187-2197.
54. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, et al. (2005) Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 65: 6934-6942.
55. Sandur SK, Deorukhkar A, Pandey MK, Pabon AM, Shentu S, et al. (2009) Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys 75: 534-542.
56. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, et al. (2002) Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 175: 165-173.
57. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG, (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985.